SKIN · Insider Trading
SkinHealth Systems Inc. Class A Common Stock
Every open-market purchase and sale reported by SKIN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Michael P. Monahan | Chief Financial Officer | F | −32,357 | −$20.71K |
| 2026-04-13 | Sheri Lewis | CSO and COO | F | −24,904 | −$22.91K |
| 2026-04-13 | Michael P. Monahan | Chief Financial Officer | F | −26,776 | −$24.63K |
| 2026-03-24 | Ronald Menezes | Chief Revenue Officer | A | +746,681 | — |
| 2026-03-24 | Pedro Bruno Ferreira Malha | President and CEO | A | +2,654,867 | — |
| 2026-03-24 | Sheri Lewis | CSO and COO | A | +746,681 | — |
| 2026-03-24 | Michael P. Monahan | Chief Financial Officer | A | +746,681 | — |
| 2026-03-19 | Ronald Menezes | Chief Revenue Officer | F | −61,471 | −$71.92K |
| 2026-03-19 | Sheri Lewis | CSO and COO | F | −51,883 | −$60.70K |
| 2026-03-19 | Michael P. Monahan | Chief Financial Officer | F | −58,573 | −$68.53K |
| 2025-11-17 | Philippe Schaison | Director | A | +57,692 | — |
| 2025-11-04 | Ronald Menezes | Chief Revenue Officer | F | −46,426 | −$66.39K |
| 2025-10-10 | Pedro Bruno Ferreira Malha | President and CEO | A | +2,190,384 | +$3.42M |
| 2025-08-12 | Michael P. Monahan | Chief Financial Officer | F | −32,357 | −$61.15K |
| 2025-06-18 | Doug K. Schillinger | Director | A | +73,051 | — |
| 2025-06-18 | Stephen J Fanning | Director | A | +73,051 | — |
| 2025-06-18 | Michelle C. Kerrick | Director | A | +73,051 | — |
| 2025-06-18 | Desiree Gruber | Director | A | +73,051 | — |
| 2025-06-18 | Brian Christopher Miller | Director | A | +73,051 | — |
| 2025-06-18 | Brent L Saunders | Director | A | +73,051 | — |
| 2025-06-03 | Michael P. Monahan | Chief Financial Officer | F | −24,290 | −$39.59K |
| 2025-04-11 | Michael P. Monahan | Chief Financial Officer | F | −26,776 | −$28.92K |
| 2025-04-11 | Marla Malcolm Beck | President and CEO | F | −92,981 | −$100.42K |
| 2025-04-11 | Sheri Lewis | CSO and COO | F | −31,296 | −$33.80K |
| 2025-03-19 | Michael P. Monahan | Chief Financial Officer | A | +639,204 | +$843.75K |
| 2025-03-19 | Ronald Menezes | Chief Revenue Officer | A | +639,204 | +$843.75K |
| 2025-03-19 | Marla Malcolm Beck | President and CEO | A | +1,832,386 | +$2.42M |
| 2025-03-19 | Sheri Lewis | CSO and COO | A | +639,204 | +$843.75K |
| 2024-12-03 | Michael P. Monahan | Chief Financial Officer | F | −24,227 | −$35.86K |
| 2024-11-21 | Desiree Gruber | Director | Sell | −14,663 | −$22.02K |
| 2024-08-13 | Michael P. Monahan | Chief Financial Officer | F | −32,274 | −$36.15K |
| 2024-08-13 | Brent L Saunders | Director | Buy | +40,450 | +$43.69K |
| 2024-07-10 | Desiree Gruber | Director | A | +78,534 | — |
| 2024-07-10 | Michelle C. Kerrick | Director | A | +78,534 | — |
| 2024-07-10 | Michael D Capellas | Director | A | +78,534 | — |
| 2024-07-10 | Doug K. Schillinger | Director | A | +78,534 | — |
| 2024-07-10 | Brian Christopher Miller | Director | A | +78,534 | — |
| 2024-07-10 | Julius Few | Director | A | +78,534 | — |
| 2024-07-10 | Brent L Saunders | Director | MIXED | +53,866 | −$322.23K |
| 2024-06-11 | Daniel Copell Watson | Chief Revenue Oficer | F | −37,173 | −$212.73K |
| 2024-06-11 | Marla Malcolm Beck | President and CEO | F | −64,218 | −$220.01K |
| 2024-04-11 | Daniel Copell Watson | Chief Revenue Oficer | A | +243,506 | — |
| 2024-04-11 | Marla Malcolm Beck | President and CEO | A | +837,662 | — |
| 2024-04-11 | Michael P. Monahan | Chief Financial Officer | A | +292,207 | — |
| 2023-12-01 | Michael P. Monahan | Chief Financial Officer | A | +176,711 | — |
| 2023-12-01 | Bradley Hauser | Chief Operating Officer | A | +176,711 | — |
| 2023-12-01 | Daniel Copell Watson | Chief Revenue Oficer | A | +156,250 | — |
| 2023-11-21 | Marla Malcolm Beck | Interim CEO | A | +213,675 | — |
| 2023-08-21 | Brian Christopher Miller | Director | Buy | +60,000 | +$348.60K |
| 2023-08-18 | Julius Few | Director | Buy | +20,454 | +$124.79K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Brent L Saunders | Director | 383,830 | $211.11K |
| Pedro Bruno Ferreira Malha | President and CEO | 242,263 | $133.24K |
| Marla Malcolm Beck | President and CEO | 137,670 | $75.72K |
| Michael P. Monahan | Chief Financial Officer | 97,764 | $53.77K |
| Ronald Menezes | Chief Revenue Officer | 87,996 | $48.40K |
| Sheri Lewis | CSO and COO | 79,231 | $43.58K |
| Stephen J Fanning | Director | 26,364 | $14.50K |
| Brian Christopher Miller | Director | 12,152 | $6.68K |
| Doug K. Schillinger | Director | 10,802 | $5.94K |
| Desiree Gruber | Director | 9,628 | $5.30K |
| Michelle C. Kerrick | Director | 9,491 | $5.22K |
| Philippe Schaison | Director | 2,885 | $1.59K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SKIN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.